Kim Kamdar, Ph.D.
About Kim Kamdar, Ph.D.
Kim Kamdar, Ph.D., is a Managing Partner at Domain Associates, LLC and serves as Chair and CEO of Aspen Neuroscience, with board roles in several other life sciences companies.
Kim Kamdar, Ph.D., Board Member
Kim Kamdar, Ph.D. serves on multiple boards within the life sciences and biotechnology sectors. Her roles encompass several high-profile organizations including Truvian Sciences, Epic Sciences, Obalon Therapeutics, Omniome, ROX Medical, Sera Prognostics, and Singular Genomics. Each of these roles places her at the forefront of advancing innovations in healthcare, diagnostics, and biotechnology.
Kim Kamdar's Education and Expertise
Kim Kamdar, Ph.D. holds a Doctorate degree in biochemistry and genetics from Emory University. Her extensive background combines deep academic rigor in biochemistry with substantial practical experience in genetics, positioning her as an expert in the fields of molecular biology and genetic research. These qualifications have fueled her contributions across various high-impact ventures within the life sciences industry.
Managing Partner at Domain Associates, LLC
As a Managing Partner at Domain Associates, LLC, Kim Kamdar plays a crucial role in steering the venture capital firm's investments in the life sciences sector. Domain Associates, known for its focus on healthcare and biotechnology companies, benefits from her insightful leadership and deep sector knowledge. This position allows her to leverage her extensive academic and research background to identify and nurture high-potential companies.
Career at Novartis
Kim Kamdar previously held the role of research director at Novartis, where she led a team dedicated to exploring the biology, genetics, and genomics of model organisms. Her work at Novartis contributed significant advancements to the understanding of genetic models, highlighting her capabilities in both leadership and research within a global pharmaceutical context.
Leadership Roles at Aspen Neuroscience
In her capacity as Chair of the board of directors and CEO of Aspen Neuroscience, Kim Kamdar oversees strategic decision-making and operational execution. Aspen Neuroscience focuses on developing personalized cell therapies for treating central nervous system diseases, reflecting her commitment to pioneering therapeutic solutions in neuroscience.